DNA IMPFSTOFFE GEGEN LASSA VIRUS

European patent · EP2731628 · In force

Register entry

Publication number
EP2731628
Application number
EP12839761
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 11, 2012
Published
May 21, 2014
Granted
Sep 4, 2019
Protection ends at the latest
Jul 10, 2032
Next annual fee due
Jul 31, 2026
IPC classes
A61P 31/14 (2006.01)
Priority
US 201161506579 P 11.07.2011
US 201161507062 P 12.07.2011
PCT application
PCT/US2012/046318 11.07.2012
PCT publication
WO2013/055418 18.04.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  5. Sep 4, 2019

    Granted

    Published in Swissreg on 04.09.2019

Parties

Holder

Inovio Pharmaceuticals, Inc.

660 W. Germantown Pike Suite 110, Plymouth Meeting, PA 19462, US

Inventor

CASHMAN, Kathleen

Purcellville, VA 20132, US

SARDESAI, Niranjan

Blue Bell, PA 19422, US

BRODERICK, Kate

San Diego, CA 92120, US

SCHMALJOHN, Connie

Middletown, MD 21769, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.